{"entity":{"type":"insider","cik":"0001861989","url":"/insider/0001861989","json_url":"/insider/0001861989.json","name":"Lehr Martin A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":12,"first":"2021-10-25","last":"2025-06-10","span_basis":"filed_date"},"name_variants":[{"name":"Lehr Martin A.","source":"filing","n_filings":12,"first_seen":"2021-10-25","last_seen":"2025-06-10"}],"transactions":[{"id":4077435,"accession":"0001842952-25-000064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001842952-25-000064","line_url":"/filing/0001842952-25-000064#line-1","is_derivative":false,"issuer_cik":"0001842952","issuer_name":"Context Therapeutics Inc.","issuer_ticker":"CNTX","issuer_name_source":null,"issuer_url":"/issuer/0001842952","owner_cik":"0001861989","owner_name":"Lehr Martin A.","owner_display_name":"Lehr Martin A.","owner_url":"/insider/0001861989","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.7008,"price_display":"0.70","price_state":"stated","total_value":70080.0,"total_display":"70,080.00","total_whole":"70,080","shares_owned_after":920190.0,"shares_owned_after_display":"920,190","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-09","filed_date":"2025-06-10","scope":"insider"},{"id":8454505,"accession":"0001842952-23-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001842952-23-000030","line_url":"/filing/0001842952-23-000030#line-1","is_derivative":false,"issuer_cik":"0001842952","issuer_name":"Context Therapeutics Inc.","issuer_ticker":"CNTX","issuer_name_source":null,"issuer_url":"/issuer/0001842952","owner_cik":"0001861989","owner_name":"Lehr Martin A.","owner_display_name":"Lehr Martin A.","owner_url":"/insider/0001861989","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5823.0,"shares_display":"5,823","price_per_share":0.8415,"price_display":"0.84","price_state":"stated","total_value":4900.0545,"total_display":"4,900.05","total_whole":"4,900","shares_owned_after":159701.0,"shares_owned_after_display":"159,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-21","filed_date":"2023-02-21","scope":"insider"},{"id":8050463,"accession":"0001842952-23-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001842952-23-000020","line_url":"/filing/0001842952-23-000020#line-1","is_derivative":false,"issuer_cik":"0001842952","issuer_name":"Context Therapeutics Inc.","issuer_ticker":"CNTX","issuer_name_source":null,"issuer_url":"/issuer/0001842952","owner_cik":"0001861989","owner_name":"Lehr Martin A.","owner_display_name":"Lehr Martin A.","owner_url":"/insider/0001861989","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5606.0,"shares_display":"5,606","price_per_share":0.8742,"price_display":"0.87","price_state":"stated","total_value":4900.7652,"total_display":"4,900.77","total_whole":"4,901","shares_owned_after":153878.0,"shares_owned_after_display":"153,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-13","scope":"insider"},{"id":8618422,"accession":"0001842952-23-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001842952-23-000017","line_url":"/filing/0001842952-23-000017#line-1","is_derivative":false,"issuer_cik":"0001842952","issuer_name":"Context Therapeutics Inc.","issuer_ticker":"CNTX","issuer_name_source":null,"issuer_url":"/issuer/0001842952","owner_cik":"0001861989","owner_name":"Lehr Martin A.","owner_display_name":"Lehr Martin A.","owner_url":"/insider/0001861989","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5040.0,"shares_display":"5,040","price_per_share":0.9723,"price_display":"0.97","price_state":"stated","total_value":4900.392,"total_display":"4,900.39","total_whole":"4,900","shares_owned_after":148272.0,"shares_owned_after_display":"148,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-06","scope":"insider"},{"id":8490718,"accession":"0001842952-23-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001842952-23-000012","line_url":"/filing/0001842952-23-000012#line-1","is_derivative":false,"issuer_cik":"0001842952","issuer_name":"Context Therapeutics Inc.","issuer_ticker":"CNTX","issuer_name_source":null,"issuer_url":"/issuer/0001842952","owner_cik":"0001861989","owner_name":"Lehr Martin A.","owner_display_name":"Lehr Martin A.","owner_url":"/insider/0001861989","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7027.0,"shares_display":"7,027","price_per_share":0.6974,"price_display":"0.70","price_state":"stated","total_value":4900.6298,"total_display":"4,900.63","total_whole":"4,901","shares_owned_after":143232.0,"shares_owned_after_display":"143,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-01-30","scope":"insider"},{"id":8307760,"accession":"0001842952-23-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001842952-23-000008","line_url":"/filing/0001842952-23-000008#line-1","is_derivative":false,"issuer_cik":"0001842952","issuer_name":"Context Therapeutics Inc.","issuer_ticker":"CNTX","issuer_name_source":null,"issuer_url":"/issuer/0001842952","owner_cik":"0001861989","owner_name":"Lehr Martin A.","owner_display_name":"Lehr Martin A.","owner_url":"/insider/0001861989","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6839.0,"shares_display":"6,839","price_per_share":0.7166,"price_display":"0.72","price_state":"stated","total_value":4900.8274,"total_display":"4,900.83","total_whole":"4,901","shares_owned_after":136205.0,"shares_owned_after_display":"136,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-23","scope":"insider"},{"id":7883632,"accession":"0001842952-23-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001842952-23-000006","line_url":"/filing/0001842952-23-000006#line-1","is_derivative":false,"issuer_cik":"0001842952","issuer_name":"Context Therapeutics Inc.","issuer_ticker":"CNTX","issuer_name_source":null,"issuer_url":"/issuer/0001842952","owner_cik":"0001861989","owner_name":"Lehr Martin A.","owner_display_name":"Lehr Martin A.","owner_url":"/insider/0001861989","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6783.0,"shares_display":"6,783","price_per_share":0.7364,"price_display":"0.74","price_state":"stated","total_value":4995.0012,"total_display":"4,995.00","total_whole":"4,995","shares_owned_after":129366.0,"shares_owned_after_display":"129,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-18","scope":"insider"},{"id":6261470,"accession":"0001842952-22-000112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001842952-22-000112","line_url":"/filing/0001842952-22-000112#line-1","is_derivative":false,"issuer_cik":"0001842952","issuer_name":"Context Therapeutics Inc.","issuer_ticker":"CNTX","issuer_name_source":null,"issuer_url":"/issuer/0001842952","owner_cik":"0001861989","owner_name":"Lehr Martin A.","owner_display_name":"Lehr Martin A.","owner_url":"/insider/0001861989","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.7398,"price_display":"0.74","price_state":"stated","total_value":14796.0,"total_display":"14,796.00","total_whole":"14,796","shares_owned_after":122583.0,"shares_owned_after_display":"122,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-19","scope":"insider"},{"id":6837479,"accession":"0001842952-22-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001842952-22-000081","line_url":"/filing/0001842952-22-000081#line-1","is_derivative":false,"issuer_cik":"0001842952","issuer_name":"Context Therapeutics Inc.","issuer_ticker":"CNTX","issuer_name_source":null,"issuer_url":"/issuer/0001842952","owner_cik":"0001861989","owner_name":"Lehr Martin A.","owner_display_name":"Lehr Martin A.","owner_url":"/insider/0001861989","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13000.0,"shares_display":"13,000","price_per_share":1.8511,"price_display":"1.85","price_state":"stated","total_value":24064.3,"total_display":"24,064.30","total_whole":"24,064","shares_owned_after":102583.0,"shares_owned_after_display":"102,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-19","filed_date":"2022-08-22","scope":"insider"},{"id":4201064,"accession":"0001842952-21-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001842952-21-000029","line_url":"/filing/0001842952-21-000029#line-1","is_derivative":false,"issuer_cik":"0001842952","issuer_name":"Context Therapeutics Inc.","issuer_ticker":"CNTX","issuer_name_source":null,"issuer_url":"/issuer/0001842952","owner_cik":"0001861989","owner_name":"Lehr Martin A.","owner_display_name":"Lehr Martin A.","owner_url":"/insider/0001861989","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13000.0,"shares_display":"13,000","price_per_share":3.2192,"price_display":"3.22","price_state":"stated","total_value":41849.6,"total_display":"41,849.60","total_whole":"41,850","shares_owned_after":820190.0,"shares_owned_after_display":"820,190","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-16","filed_date":"2021-12-20","scope":"insider"},{"id":9296462,"accession":"0001842952-21-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001842952-21-000027","line_url":"/filing/0001842952-21-000027#line-1","is_derivative":false,"issuer_cik":"0001842952","issuer_name":"Context Therapeutics Inc.","issuer_ticker":"CNTX","issuer_name_source":null,"issuer_url":"/issuer/0001842952","owner_cik":"0001861989","owner_name":"Lehr Martin A.","owner_display_name":"Lehr Martin A.","owner_url":"/insider/0001861989","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":807190.0,"shares_owned_after_display":"807,190","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-22","filed_date":"2021-12-17","scope":"insider"},{"id":5217691,"accession":"0001179110-21-009609","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-21-009609","line_url":"/filing/0001179110-21-009609#line-4","is_derivative":false,"issuer_cik":"0001842952","issuer_name":"Context Therapeutics Inc.","issuer_ticker":"CNTX","issuer_name_source":null,"issuer_url":"/issuer/0001842952","owner_cik":"0001861989","owner_name":"Lehr Martin A.","owner_display_name":"Lehr Martin A.","owner_url":"/insider/0001861989","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":99583.0,"shares_owned_after_display":"99,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-22","filed_date":"2021-10-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001842952","name":"Context Therapeutics Inc.","url":"/issuer/0001842952","role":"Director, Officer (Chief Executive Officer)","n_filings":12,"first_seen":"2021-10-25","last_seen":"2025-06-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001861989","retrieved_at":"2026-08-22T17:32:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}